MALMED issues approval for import of Trikafta for eight most critical cystic fibrosis patients


The interventional import of the Trikafta medication intended for the eight patients with cystic fibrosis who are in the most critical condition, has been officially approved by the Agency for Medicines MALMED.

This was confirmed for MIA by the director of the Agency, LjirimShabani, who pointed out that all the procedures for approving the import of the drug have been completed. The procedure still remains to be implemented.

Previous articleBomb threatsto 12 schools and the Skopje airport are false, MoIclaims
Next articleSkopje’s PPOopens investigation intoLatas and Lazarov’s interview


Please enter your comment!
Please enter your name here